Defining Rare Diseases in Newborns, Before the First Symptoms: Dijon's CHU

franceinfo.fr

Lean Left

Factuality

Ownership

Dijon's UHC is launching Phase 2 of its neonatal genomic screening program to detect more than 200 rare genetic diseases in infants and initiate treatment prior to the onset of the first symptoms.

bienpublic.com

Factuality

Ownership

On Thursday, July 9, the University Hospital (CHU) of Dijon presented the second phase of its research project on neonatal screening. Entitled Perigenomed, it aims to screen approximately 200 rare diseases in 19,000 newborns in order to provide early intervention. This paves the way for a possible nationwide expansion of the program.